Can you comment on de-escalation strategy in breast cancer surgery and axillary surgery?
Rita SAKR
surgeon, Dubai
surgeon, Dubai
Genetic assessment and management in high-risk patients.
Pascal PUJOL
Genetician, Montpellier, France
Innovations in breast metastatic cancer
Frédérique PENAULT LLORCA Pathologist, Clermont Ferrand, France
FDG Pet CTscan for treatment response evaluation.
Willy VANGU
Nuclear Medicine, Johannesburg, South Africa
What are the goals of AROME?
Jospeh GLIGOROV
oncologist, Paris, France